Racial differences in survival after diagnosis with primary malignant brain tumor

Cancer

Volumn 98, Issue 3, 2003, Pages 603-609

  Barnholtz Sloan, Jill S ^a,b,c   Sloan, Andrew E ^a,b   Schwartz, Ann G ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Brain tumor; Prognostic variables; Race; Survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN TUMOR; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; CENTRAL NERVOUS SYSTEM TUMOR; CHI SQUARE DISTRIBUTION; ETHNIC GROUP; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; NEGRO; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CAUSE OF DEATH; EPIDEMIOLOGIC STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OLIGODENDROGLIOMA; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE;

EID: 0038637493     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11534     Document Type: Article

References (27)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Mahaley MS Jr., Mettlin C, Natarajan N, Laws ER Jr., Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989;71:826-836.
3. American Cancer Society. Cancer facts and figures, 2003. Atlanta: American Cancer Society, 2003.
4. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1973-1999 [monograph]. Bethesda: National Cancer Institute, 2002.
5. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the US, 1995-1999. Chicago: Central Brain Tumor Registry of the United States, 2002.
6. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-oncol. 1999;1:14-25.
7. Mahaley MS Jr., Mettlin C, Natarajan N, Laws ER Jr., Peace BB. Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS. Clin Neurosurg. 1990;36:347-352.
8. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-oncol. 2002;4:278-299.
9. Legler JM, Ries LAG, Smith MA, et al. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91:1382-1390.
10. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primary malignant brain tumors: Surveillance, Epidemiology, and End Results (SEER) data. Cancer. 1999;85:485-491.
11. Surawicz TS, Davis F, Freels S, Laws ER Jr., Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol. 1998;40:151-160.
12. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991;133:672-682.
13. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
14. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
15. Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
16. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985-1993.
17. Barnholtz-Sloan JS, Tainsky MA, Abrams J, et al. Ethnic differences in survival among women with ovarian carcinoma. Cancer. 2002;94:1886-1893.
18. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998;88:1-10.
19. Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer. 1995;75:330-337.
20. National Cancer Institute, National Institutes of Health. Surveillance, Epidemiology and End Results (SEER) Program. Bethesda: National Cancer Institute, 2002.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;30:248-275.
23. Klein JP, Moeschberger ML. Survival analysis. New York: Springer-Verlag, 1998.
24. SAS, Inc. Statistical analysis software (Version 8.1). Cary, NC: SAS, Inc., 2001.
25. Insightful Corp. Splus (Version 6.0 Professional). Seattle: Insightful Corp., 2002.
26. Kwok RK, Yankaskas BC. The use of census data for determining race and education as SES indicators: a validation study. Ann Epidemiol. 2001;11:171-177.
27. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA. 1996;275:794-796.